{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:21:18Z","timestamp":1791404478229,"version":"4.3.3"},"reference-count":100,"publisher":"IMR Press","issue":"2","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Human Resources and Social Security Department System of Shanxi Province","award":["20210001"],"award-info":[{"award-number":["20210001"]}]},{"DOI":"10.13039\/501100003398","name":"Shanxi Scholarship Council of China","doi-asserted-by":"crossref","award":["2021-116"],"award-info":[{"award-number":["2021-116"]}],"id":[{"id":"10.13039\/501100003398","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanxi \u2018136\u2019 Leading Clinical Key Specialty","award":["2019XY002"],"award-info":[{"award-number":["2019XY002"]}]},{"name":"Shanxi Provincial Key Laboratory of Hepatobiliary and Pancreatic Diseases"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>The incidence and mortality from malignant tumors continue to rise each year. Consequently, early diagnosis and intervention are vital for improving patient\u2019 prognosis and survival. The traditional pathological tissue biopsy is currently considered the gold standard for cancer diagnosis. However, it suffers from several limitations including invasiveness, sometimes not repeatable or unsuitable, and the inability to capture the dynamic nature of tumors in terms of space and time. Consequently, these limit the application of tissue biopsies for the diagnosis of early-stage tumors and have redirected the research focus towards liquid biopsies. Blood-based liquid biopsies have thus emerged as a promising option for non-invasive assessment of tumor-specific biomarkers. These minimally invasive, easily accessible, and reproducible tests offer several advantages, such as being mostly complication-free and efficient at monitoring tumor progression and tracing drug resistance. Liquid biopsies show great potential for cancer prediction, diagnosis, and prognostic assessment. Circulating tumor-educated platelets (TEPs) possess the unique ability to absorb nucleic acids from the bloodstream and to modify transcripts derived from megakaryocytes in response to external signals. In addition, circulating free RNA (cfRNA) constitutes a significant portion of the biomolecules present in the bloodstream. This paper aims to provide a comprehensive overview of the current research status regarding TEP RNA and cfRNA in liquid biopsies from various tumor types. Our analysis includes cancers of the lung, liver, pancreas, breast, nasopharynx, ovary and colon, as well as multiple myeloma and sarcoma. By synthesizing this information, we intend to establish a solid theoretical foundation for exploring potential applications of circulating RNA as a reliable biomarker for tumor diagnosis and monitoring.<\/jats:p>","DOI":"10.31083\/j.fbl2902080","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T08:19:30Z","timestamp":1708676370000},"source":"Crossref","is-referenced-by-count":21,"title":["Tumor-Educated Platelet RNA and Circulating Free RNA: Emerging Liquid Biopsy Markers for Different Tumor Types"],"prefix":"10.31083","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7187-0244","authenticated-orcid":true,"given":"Haiyang","family":"Hu","sequence":"first","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, 030032 Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangqin","family":"Song","sequence":"first","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, 030032 Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Han","sequence":"first","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, 030032 Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-9357","authenticated-orcid":true,"given":"Haoliang","family":"Zhao","sequence":"first","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, 030032 Taiyuan, Shanxi, China"},{"name":"Department of Hepatobiliary Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, 030032 Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiefeng","family":"He","sequence":"first","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, 030032 Taiyuan, Shanxi, China"},{"name":"Department of Hepatobiliary Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, 030032 Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2015; 136: E359\u2013E386.","DOI":"10.1002\/ijc.29210"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pi\u00f1eros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. International Journal of Cancer. 2019; 144: 1941\u20131953.","DOI":"10.1002\/ijc.31937"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Ili\u00e9 M, Hofman P. Pros: Can tissue biopsy be replaced by liquid biopsy? Translational Lung Cancer Research. 2016; 5: 420\u2013423.","DOI":"10.21037\/tlcr.2016.08.06"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Siravegna G, Marsoni S, Siena S, Bardelli A. Integrating liquid biopsies into the management of cancer. Nature Reviews. Clinical Oncology. 2017; 14: 531\u2013548.","DOI":"10.1038\/nrclinonc.2017.14"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Eslami-S Z, Cort\u00e9s-Hern\u00e1ndez LE, Cayrefourcq L, Alix-Panabi\u00e8res C. The Different Facets of Liquid Biopsy: A Kaleidoscopic View. Cold Spring Harbor Perspectives in Medicine. 2020; 10: a037333.","DOI":"10.1101\/cshperspect.a037333"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Shah UJ, Alsulimani A, Ahmad F, Mathkor DM, Alsaieedi A, Harakeh S, et al. Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications. Biotechnology & Genetic Engineering Reviews. 2022; 38: 339\u2013383.","DOI":"10.1080\/02648725.2022.2108994"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Martins I, Ribeiro IP, Jorge J, Gon\u00e7alves AC, Sarmento-Ribeiro AB, Melo JB, et al. Liquid Biopsies: Applications for Cancer Diagnosis and Monitoring. Genes. 2021; 12: 349.","DOI":"10.3390\/genes12030349"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Cossu AM, Scrima M, Lombardi A, Grimaldi A, Russo M, Ottaiano A, et al. Future directions and management of liquid biopsy in non-small cell lung cancer. Exploration of Targeted Anti-tumor Therapy. 2020; 1: 239\u2013252.","DOI":"10.37349\/etat.2020.00015"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez J, Avila J, Rolfo C, Ru\u00edz-Pati\u00f1o A, Russo A, Ricaurte L, et al. When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review. Oncology and Therapy. 2021; 9: 89\u2013110.","DOI":"10.1007\/s40487-021-00144-6"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"In \u2018t Veld SGJG, Wurdinger T. Tumor-educated platelets. Blood. 2019; 133: 2359\u20132364.","DOI":"10.1182\/blood-2018-12-852830"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Antunes-Ferreira M, Koppers-Lalic D, W\u00fcrdinger T. Circulating platelets as liquid biopsy sources for cancer detection. Molecular Oncology. 2021; 15: 1727\u20131743.","DOI":"10.1002\/1878-0261.12859"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ma C, Fu Q, Diggs LP, McVey JC, McCallen J, Wabitsch S, et al. Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD. Cancer Cell. 2022; 40: 986\u2013998.e5.","DOI":"10.1016\/j.ccell.2022.08.004"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Zhang Q, Liu H, Zhu Q, Zhan P, Zhu S, Zhang J, et al. Patterns and functional implications of platelets upon tumor \u201ceducation\u201d. The International Journal of Biochemistry & Cell Biology. 2017; 90: 68\u201380.","DOI":"10.1016\/j.biocel.2017.07.018"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Jiang X, Wong KHK, Khankhel AH, Zeinali M, Reategui E, Phillips MJ, et al. Microfluidic isolation of platelet-covered circulating tumor cells. Lab on a Chip. 2017; 17: 3498\u20133503.","DOI":"10.1039\/C7LC00654C"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Varkey J, Nicolaides T. Tumor-Educated Platelets: A Review of Current and Potential Applications in Solid Tumors. Cureus. 2021; 13: e19189.","DOI":"10.7759\/cureus.19189"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Heeke S, Mograbi B, Alix-Panabi\u00e8res C, Hofman P. Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment. Cells. 2019; 8: 714.","DOI":"10.3390\/cells8070714"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Green SM, Padula MP, Marks DC, Johnson L. The Lipid Composition of Platelets and the Impact of Storage: An Overview. Transfusion Medicine Reviews. 2020; 34: 108\u2013116.","DOI":"10.1016\/j.tmrv.2019.12.001"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Smith CW. Release of \u03b1-granule contents during platelet activation. Platelets. 2022; 33: 491\u2013502.","DOI":"10.1080\/09537104.2021.1913576"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011; 20: 576\u2013590.","DOI":"10.1016\/j.ccr.2011.09.009"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Liu Y, Zhang Y, Ding Y, Zhuang R. Platelet-mediated tumor metastasis mechanism and the role of cell adhesion molecules. Critical Reviews in Oncology\/hematology. 2021; 167: 103502.","DOI":"10.1016\/j.critrevonc.2021.103502"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Wang L, Wang X, Guo E, Mao X, Miao S. Emerging roles of platelets in cancer biology and their potential as therapeutic targets. Frontiers in Oncology. 2022; 12: 939089.","DOI":"10.3389\/fonc.2022.939089"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"D\u2019Ambrosi S, Nilsson RJ, Wurdinger T. Platelets and tumor-associated RNA transfer. Blood. 2021; 137: 3181\u20133191.","DOI":"10.1182\/blood.2019003978"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Strasenburg W, J\u00f3\u017awicki J, Dur\u015blewicz J, Kuffel B, Kulczyk MP, Kowalewski A, et al. Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy. Frontiers in Oncology. 2022; 12: 909767.","DOI":"10.3389\/fonc.2022.909767"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Best MG, Sol N, Kooi I, Tannous J, Westerman BA, Rustenburg F, et al. RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics. Cancer Cell. 2015; 28: 666\u2013676.","DOI":"10.1016\/j.ccell.2015.09.018"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Poulet G, Massias J, Taly V. Liquid Biopsy: General Concepts. Acta Cytologica. 2019; 63: 449\u2013455.","DOI":"10.1159\/000499337"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Sunderland N, Skroblin P, Barwari T, Huntley RP, Lu R, Joshi A, et al. MicroRNA Biomarkers and Platelet Reactivity: The Clot Thickens. Circulation Research. 2017; 120: 418\u2013435.","DOI":"10.1161\/CIRCRESAHA.116.309303"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Sorber L, Zwaenepoel K, Deschoolmeester V, Van Schil PEY, Van Meerbeeck J, Lardon F, et al. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. Lung Cancer (Amsterdam, Netherlands). 2017; 107: 100\u2013107.","DOI":"10.1016\/j.lungcan.2016.04.026"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians. 2018; 68: 394\u2013424.","DOI":"10.3322\/caac.21492"},{"key":"ref29","unstructured":"Zheng RS, Zhang SW, Sun KX, Chen R, Wang SM, Li L, et al. Cancer statistics in China, 2016. Zhonghua Zhong Liu Za Zhi. 2023; 45: 212\u2013220. (In Chinese)"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Liu L, Lin F, Ma X, Chen Z, Yu J. Tumor-educated platelet as liquid biopsy in lung cancer patients. Critical Reviews in Oncology\/hematology. 2020; 146: 102863.","DOI":"10.1016\/j.critrevonc.2020.102863"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Nooreldeen R, Bach H. Current and Future Development in Lung Cancer Diagnosis. International Journal of Molecular Sciences. 2021; 22: 8661.","DOI":"10.3390\/ijms22168661"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Li X, Liu L, Song X, Wang K, Niu L, Xie L, et al. TEP linc-GTF2H2-1, RP3-466P17.2, and lnc-ST8SIA4-12 as novel biomarkers for lung cancer diagnosis and progression prediction. Journal of Cancer Research and Clinical Oncology. 2021; 147: 1609\u20131622.","DOI":"10.1007\/s00432-020-03502-5"},{"key":"ref33","unstructured":"Xue L, Xie L, Song X, Song X. Expression and Significance of ACIN1 mRNA in Platelets of Lung Cancer. Zhongguo Fei Ai Za Zhi = Chinese Journal of Lung Cancer. 2018; 21: 677\u2013681."},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Xing S, Zeng T, Xue N, He Y, Lai YZ, Li HL, et al. Development and Validation of Tumor-educated Blood Platelets Integrin Alpha 2b (ITGA2B) RNA for Diagnosis and Prognosis of Non-small-cell Lung Cancer through RNA-seq. International Journal of Biological Sciences. 2019; 15: 1977\u20131992.","DOI":"10.7150\/ijbs.36284"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Nilsson RJA, Karachaliou N, Berenguer J, Gimenez-Capitan A, Schellen P, Teixido C, et al. Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer. Oncotarget. 2016; 7: 1066\u20131075.","DOI":"10.18632\/oncotarget.6279"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Fan L, Qi H, Teng J, Su B, Chen H, Wang C, et al. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine. 2016; 37: 7777\u20137784.","DOI":"10.1007\/s13277-015-4608-3"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Vorperian SK, Moufarrej MN, Tabula Sapiens Consortium, Quake SR. Cell types of origin of the cell-free transcriptome. Nature Biotechnology. 2022; 40: 855\u2013861.","DOI":"10.1101\/2021.05.05.441859"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Wei J, Liu LK, Gao W, Zhu CJ, Liu YQ, Cheng T, et al. Reduction of Plasma MicroRNA-21 is Associated with Chemotherapeutic Response in Patients with Non-small Cell Lung Cancer. Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu. 2011; 23: 123\u2013128.","DOI":"10.1007\/s11670-011-0123-2"},{"key":"ref39","unstructured":"Lianyu Y, Yu W, Kai C, Ming C. Application of tumor educated platelets derived miRNA-122 and miRNA-21 in the early diagnosis of liver cancer. International Journal of Laboratory Medicine. 2022; 43: 519\u2013522."},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse JL, et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prevention Research (Philadelphia, Pa.). 2009; 2: 807\u2013813.","DOI":"10.1158\/1940-6207.CAPR-09-0094"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Li W, Wang Y, Zhang Q, Tang L, Liu X, Dai Y, et al. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer. PloS One. 2015; 10: e0134220.","DOI":"10.1371\/journal.pone.0134220"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Bertoli E, De Carlo E, Basile D, Zara D, Stanzione B, Schiappacassi M, et al. Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications. International Journal of Molecular Sciences. 2023; 24: 10803.","DOI":"10.3390\/ijms241310803"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Xin L, Yue Y, Zihan R, Youbin C, Tianyu L, Rui W. Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer. Frontiers in Physiology. 2023; 14: 1200124.","DOI":"10.3389\/fphys.2023.1200124"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Ahmed M, Wuethrich A, Constantin N, Shanmugasundaram KB, Mainwaring P, Kulasinghe A, et al. Liquid Biopsy Snapshots of Key Phosphoproteomic Pathways in Lung Cancer Patients for Diagnosis and Therapy Monitoring. Analytical Chemistry. 2023; 95: 8522\u20138532.","DOI":"10.1021\/acs.analchem.3c00519"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Vandekerckhove O, Cuppens K, Pat K, Du Pont B, Froyen G, Maes B. Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical Applications. Cancers. 2023; 15: 2702.","DOI":"10.3390\/cancers15102702"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Petrick JL, Florio AA, Loomba R, McGlynn KA. Have incidence rates of liver cancer peaked in the United States? Cancer. 2020; 126: 3151\u20133155.","DOI":"10.1002\/cncr.32794"},{"key":"ref47","unstructured":"Lu Z, Haozhen R, Xiaolei S. Predictive value of preoperative clinical indicators for microvascular invasion in hepatocellular carcinoma. Journal of Hepatopancreatobiliary Surgery. 2023; 35: 13\u201318."},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Evangelista J, Zaninotto E, Gaglio A, Ghidini M, Raimondi L. MicroRNAs as Diagnostic Tools in Hepatocellular Carcinoma. Gastrointestinal Disorders. 2021; 3: 237\u2013246.","DOI":"10.3390\/gidisord3040022"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Shi BM, Lu W, Ji K, Wang YF, Xiao S, Wang XY. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology. 2017; 23: 3713\u20133720.","DOI":"10.3748\/wjg.v23.i20.3713"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Zhu B, Gu S, Wu X, He W, Zhou H. Bioinformatics analysis of tumor-educated platelet microRNAs in patients with hepatocellular carcinoma. Bioscience Reports. 2021; 41: BSR20211420.","DOI":"10.1042\/BSR20211420"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Okajima W, Komatsu S, Ichikawa D, Miyamae M, Kawaguchi T, Hirajima S, et al. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function. Oncotarget. 2016; 7: 53820\u201353836.","DOI":"10.18632\/oncotarget.10781"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Lin L, Lu B, Yu J, Liu W, Zhou A. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage. Clinics and Research in Hepatology and Gastroenterology. 2016; 40: 397\u2013404.","DOI":"10.1016\/j.clinre.2015.11.005"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Zhuang LP, Meng ZQ. Serum miR-224 reflects stage of hepatocellular carcinoma and predicts survival. BioMed Research International. 2015; 2015: 731781.","DOI":"10.1155\/2015\/731781"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Ratnasari N, Lestari P, Renovaldi D, Raditya Ningsih J, Qoriansas N, Wardana T, et al. Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients. PloS One. 2022; 17: e0263298.","DOI":"10.1371\/journal.pone.0263298"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Zhang W, Fu T, Guo Z, Zhang Y, Zhang L, Su H, et al. Serum miR-375 Levels Are Closely Related to Disease Progression from HBV Infection to HBV-Related Hepatocellular Carcinoma. BioMed Research International. 2020; 2020: 5819385.","DOI":"10.1155\/2020\/5819385"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Martin-Perez E, Dom\u00ednguez-Mu\u00f1oz JE, Botella-Romero F, Cerezo L, Matute Teresa F, Serrano T, et al. Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer. Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2020; 22: 1963\u20131975.","DOI":"10.1007\/s12094-020-02350-6"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World Journal of Gastroenterology. 2018; 24: 4846\u20134861.","DOI":"10.3748\/wjg.v24.i43.4846"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Chu NJ, Anders RA, Fertig EJ, Cao M, Hopkins AC, Keenan BP, et al. Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development. Cancer Prevention Research (Philadelphia, Pa.). 2020; 13: 569\u2013582.","DOI":"10.1158\/1940-6207.CAPR-20-0053"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Vila-Navarro E, Duran-Sanchon S, Vila-Casades\u00fas M, Moreira L, Gin\u00e8s \u00c0, Cuatrecasas M, et al. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia. Clinical and Translational Gastroenterology. 2019; 10: e00029.","DOI":"10.14309\/ctg.0000000000000029"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Cao Z, Liu C, Xu J, You L, Wang C, Lou W, et al. Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study. Oncotarget. 2016; 7: 41575\u201341583.","DOI":"10.18632\/oncotarget.9491"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Xu J, Cao Z, Liu W, You L, Zhou L, Wang C, et al. Plasma miRNAs Effectively Distinguish Patients with Pancreatic Cancer From Controls: A Multicenter Study. Annals of Surgery. 2016; 263: 1173\u20131179.","DOI":"10.1097\/SLA.0000000000001345"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Mazza T, Gioffreda D, Fontana A, Biagini T, Carella M, Palumbo O, et al. Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer. Frontiers in Oncology. 2020; 10: 44.","DOI":"10.3389\/fonc.2020.00044"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Liu G, Shao C, Li A, Zhang X, Guo X, Li J. Diagnostic Value of Plasma miR-181b, miR-196a, and miR-210 Combination in Pancreatic Cancer. Gastroenterology Research and Practice. 2020; 2020: 6073150.","DOI":"10.1155\/2020\/6073150"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Gablo N, Trachtova K, Prochazka V, Hlavsa J, Grolich T, Kiss I, et al. Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection. Journal of Clinical Medicine. 2020; 9: 2440.","DOI":"10.3390\/jcm9082440"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA: a Cancer Journal for Clinicians. 2021; 71: 7\u201333.","DOI":"10.3322\/caac.21654"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: a Cancer Journal for Clinicians. 2015; 65: 5\u201329.","DOI":"10.3322\/caac.21254"},{"key":"ref67","unstructured":"Shao B, Huiping L, Zhu J, Di L, Song G, Jiang H, et al. Plasma mi RNA expression could predict clinicopathological characteristics and chemosensitivity in patients with metastatic breast cancer. Oncolgy Progress. 2015; 13: 106\u2013113."},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Sun Y, Wang M, Lin G, Sun S, Li X, Qi J, et al. Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PloS One. 2012; 7: e47003.","DOI":"10.1371\/journal.pone.0047003"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Zhang K, Luo Z, Zhang Y, Zhang L, Wu L, Liu L, et al. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer. Cancer Biomarkers: Section a of Disease Markers. 2016; 17: 187\u2013194.","DOI":"10.3233\/CBM-160630"},{"key":"ref70","unstructured":"Anli C, Haoyuan S, Shixiong Y, Chunyan D, Chaohua H, Hanzhong L, et al. Predictive value of plasma long non-coding RNA H19 in neoadjuvant therapy for breast cancer. China Oncology. 2022; 32: 727\u2013735."},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Shimomura A, Shiino S, Kawauchi J, Takizawa S, Sakamoto H, Matsuzaki J, et al. Novel combination of serum microRNA for detecting breast cancer in the early stage. Cancer Science. 2016; 107: 326\u2013334.","DOI":"10.1111\/cas.12880"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Yao B, Qu S, Hu R, Gao W, Jin S, Ju J, et al. Delivery of platelet TPM3 mRNA into breast cancer cells via microvesicles enhances metastasis. FEBS Open Bio. 2019; 9: 2159\u20132169.","DOI":"10.1002\/2211-5463.12759"},{"key":"ref73","unstructured":"Shah AB, Nagalli S. Nasopharyngeal Carcinoma. StatPearls Publishing: Treasure Island (FL). 2023."},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Wang H, Wei X, Wu B, Su J, Tan W, Yang K. Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis. Cancer Management and Research. 2019; 11: 3351\u20133360.","DOI":"10.2147\/CMAR.S195654"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Wei J, Meng X, Wei X, Zhu K, Du L, Wang H. Down-regulated lncRNA ROR in tumor-educated platelets as a liquid-biopsy biomarker for nasopharyngeal carcinoma. Journal of Cancer Research and Clinical Oncology. 2023; 149: 4403\u20134409.","DOI":"10.1007\/s00432-022-04350-1"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"El-Arabey AA, Abdalla M, Abd-Allah AR. GATA3 and stemness of high-grade serous ovarian carcinoma: novel hope for the deadliest type of ovarian cancer. Human Cell. 2020; 33: 904\u2013906.","DOI":"10.1007\/s13577-020-00368-0"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Gao YC, Wu J. MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine. 2015; 36: 4843\u20134850.","DOI":"10.1007\/s13277-015-3138-3"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Agah S, Akbari A, Talebi A, Masoudi M, Sarveazad A, Mirzaei A, et al. Quantification of Plasma Cell-Free Circulating DNA at Different Stages of Colorectal Cancer. Cancer Investigation. 2017; 35: 625\u2013632.","DOI":"10.1080\/07357907.2017.1408814"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Tsai WS, Chen JS, Shao HJ, Wu JC, Lai JM, Lu SH, et al. Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients. Scientific Reports. 2016; 6: 24517.","DOI":"10.1038\/srep24517"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Yang Y, Junjie P, Sanjun C, Ma Y. Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions. Journal of Cancer. 2017; 8: 3212\u20133225.","DOI":"10.7150\/jca.19794"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nature Reviews. Genetics. 2014; 15: 7\u201321.","DOI":"10.1038\/nrg3606"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Zhang H, Chen Z, Wang X, Huang Z, He Z, Chen Y. Long non-coding RNA: a new player in cancer. Journal of Hematology & Oncology. 2013; 6: 37.","DOI":"10.1186\/1756-8722-6-37"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Abedini P, Fattahi A, Agah S, Talebi A, Beygi AH, Amini SM, et al. Expression analysis of circulating plasma long noncoding RNAs in colorectal cancer: The relevance of lncRNAs ATB and CCAT1 as potential clinical hallmarks. Journal of Cellular Physiology. 2019; 234: 22028\u201322033.","DOI":"10.1002\/jcp.28765"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Yang L, Jiang Q, Li DZ, Zhou X, Yu DS, Zhong J. TIMP1 mRNA in tumor-educated platelets is diagnostic biomarker for colorectal cancer. Aging. 2019; 11: 8998\u20139012.","DOI":"10.18632\/aging.102366"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Xu L, Li X, Li X, Wang X, Ma Q, She D, et al. RNA profiling of blood platelets noninvasively differentiates colorectal cancer from healthy donors and noncancerous intestinal diseases: a retrospective cohort study. Genome Medicine. 2022; 14: 26.","DOI":"10.1186\/s13073-022-01033-x"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Li X, Chen X, Gong S, Zhao J, Yao C, Zhu H, et al. Platelets promote CRC by activating the C5a\/C5aR1 axis via PSGL-1\/JNK\/STAT1 signaling in tumor-associated macrophages. Theranostics. 2023; 13: 2040\u20132056.","DOI":"10.7150\/thno.80555"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Zhuang Q, Xiang L, Xu H, Fang F, Xing C, Liang B, et al. The independent association of mean platelet volume with overall survival in multiple myeloma. Oncotarget. 2016; 7: 62640\u201362646.","DOI":"10.18632\/oncotarget.11551"},{"key":"ref88","unstructured":"Gao P, Xiao ZP, Fu K, Han M. Clinical Significance of Mean Platelet Volume Determination in Multiple Myeloma. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017; 25: 827\u2013831. (In Chinese)"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Allegra A, Cancemi G, Mirabile G, Tonacci A, Musolino C, Gangemi S. Circulating Tumour Cells, Cell Free DNA and Tumour-Educated Platelets as Reliable Prognostic and Management Biomarkers for the Liquid Biopsy in Multiple Myeloma. Cancers. 2022; 14: 4136.","DOI":"10.3390\/cancers14174136"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Heinhuis KM, In \u2018t Veld SGJG, Dwarshuis G, van den Broek D, Sol N, Best MG, et al. RNA-Sequencing of Tumor-Educated Platelets, a Novel Biomarker for Blood-Based Sarcoma Diagnostics. Cancers. 2020; 12: 1372.","DOI":"10.3390\/cancers12061372"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Yuan T, Huang X, Woodcock M, Du M, Dittmar R, Wang Y, et al. Plasma extracellular RNA profiles in healthy and cancer patients. Scientific Reports. 2016; 6: 19413.","DOI":"10.1038\/srep19413"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Yan Q, Hu D, Li M, Chen Y, Wu X, Ye Q, et al. The Serum MicroRNA Signatures for Pancreatic Cancer Detection and Operability Evaluation. Frontiers in Bioengineering and Biotechnology. 2020; 8: 379.","DOI":"10.3389\/fbioe.2020.00379"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Reinert T, Henriksen TV, Christensen E, Sharma S, Salari R, Sethi H, et al. Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients with Stages I to III Colorectal Cancer. JAMA Oncology. 2019; 5: 1124\u20131131.","DOI":"10.1001\/jamaoncol.2019.0528"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Christensen E, Birkenkamp-Demtr\u00f6der K, Sethi H, Shchegrova S, Salari R, Nordentoft I, et al. Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients with Urothelial Bladder Carcinoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2019; 37: 1547\u20131557.","DOI":"10.1200\/JCO.18.02052"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Razavi P, Li BT, Brown DN, Jung B, Hubbell E, Shen R, et al. High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants. Nature Medicine. 2019; 25: 1928\u20131937.","DOI":"10.1038\/s41591-019-0652-7"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Sanchez C, Snyder MW, Tanos R, Shendure J, Thierry AR. New insights into structural features and optimal detection of circulating tumor DNA determined by single-strand DNA analysis. NPJ Genomic Medicine. 2018; 3: 31.","DOI":"10.1038\/s41525-018-0069-0"},{"key":"ref97","doi-asserted-by":"crossref","unstructured":"Ghorbanizamani F, Moulahoum H, Guler Celik E, Zihnioglu F, Beduk T, Goksel T, et al. Design of Polymeric Surfaces as Platforms for Streamlined Cancer Diagnostics in Liquid Biopsies. Biosensors. 2023; 13: 400.","DOI":"10.3390\/bios13030400"},{"key":"ref98","unstructured":"Fei W, Huafei L, Xiangyang G, Sijia M, Fang L, Shangli C, et al. Current situation and prospect of liquid biopsy in cancer screening. Chinese Journal of Health Management. 2022; 16: 411\u2013423."},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"Yang L, Lv Z, Xia W, Zhang W, Xin Y, Yuan H, et al. The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study. Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2018; 20: 912\u2013921.","DOI":"10.1007\/s12094-017-1806-z"},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"Gareau AJ, Brien C, Gebremeskel S, Liwski RS, Johnston B, Bezuhly M. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer. Clinical & Experimental Metastasis. 2018; 35: 25\u201335.","DOI":"10.1007\/s10585-018-9874-1"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/29\/2\/10.31083\/j.fbl2902080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T13:54:29Z","timestamp":1732715669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/29\/2\/10.31083\/j.fbl2902080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2768-6701(23)01148-6"],"URL":"https:\/\/doi.org\/10.31083\/j.fbl2902080","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]},"article-number":"80"}}